Public Health


Healthcare Publication

Beyond the Step Change: What GLP 1s Solved - and What They Didn’t

Discover how pipeline data, capital allocation and physician behavior are converging — and what that means for portfolio strategy, BD, and evidence planning in obesity and beyond.

Heading into 2026 midterms, Americans back policies targeting lower healthcare costs

Latest Axios/Ipsos American Health Index: Americans support renewed health insurance subsidies, ongoing mail access of mifepristone; GLP-1 use continues to climb
Public Health Survey

Americans care about oral health, but miss connection to whole body health

A P&G and American Academy of Family Physicians survey explores American dental habits and Americans' understanding of the connection between dental health and full body health.
Public Health Survey

We’re mostly exhausted, but women really are

Six in ten Americans have often felt stressed, nervous or exhausted in past month, according to the Ipsos Consumer Tracker.

What’s changed and what hasn’t in our food habits

More than half (57%) of Americans say they prioritize foods with protein, according to the Ipsos Consumer Tracker.
Healthcare Publication

The Longevity Shift: Strategic implications of the longevity medicine revolution

Turn longevity from trend to strategy: where should pharma play - and how to win?
Healthcare Survey

Low awareness of GLP-1s globally, but high in the most advanced economies

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.

Obesity Week

This is a conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations.
Public Health Webinar

EPHMRA: Human Factors for Devices & Drugs

Ipsos is delighted to join EPHMRA for a 45-minute webinar discussion that will move beyond the basics to explore the application of HF research today.